const data = JSON.stringify(
{
    totalTweets: 137,
    totalPositiveTweets: 117,
    totalNegativeTweets: 20,
    totalNeutralTweets: 0,

    tweets: [{
    "uniqueID": 1,
    "drugName": "Bentracimab",
    "condition": "Antidote for Ticagrelor (Brilinta)",
    "review": "Used Bentracimab after taking Brilinta. It worked quickly and effectively. No side effects. Very satisfied. FDA approved the use.",
    "rating": 9,
    "date": "2023-05-15",
    "usefulCount": 15,
    "sentiment": "Positive",
    "namedEntities": ["Bentracimab", "Brilinta", "FDA"]
  },
  {
    "uniqueID": 2,
    "drugName": "Bentracimab",
    "condition": "Antidote for Ticagrelor (Brilinta)",
    "review": "Had to use Bentracimab due to Brilinta side effects. Immediate relief. Grateful for this antidote. Experienced discomfort during the clinical trial phase.",
    "rating": 8,
    "date": "2023-06-02",
    "usefulCount": 12,
    "sentiment": "Positive",
    "namedEntities": ["Bentracimab", "Brilinta", "Clinical Trial"]
  },
  {
    "uniqueID": 3,
    "drugName": "Bentracimab",
    "condition": "Antidote for Ticagrelor (Brilinta)",
    "review": "The effectiveness of Bentracimab is impressive. It resolved my Brilinta-related issues without any complications. Highly recommended. Participated in a trial at a leading research institution.",
    "rating": 10,
    "date": "2023-07-12",
    "usefulCount": 20,
    "sentiment": "Positive",
    "namedEntities": ["Bentracimab", "Brilinta", "Clinical Trial"]
  },
  {
    "uniqueID": 4,
    "drugName": "Bentracimab",
    "condition": "Antidote for Ticagrelor (Brilinta)",
    "review": "Experienced mild discomfort after taking Brilinta, but Bentracimab quickly alleviated the symptoms. Grateful for its rapid action. Displeased with the regulatory process.",
    "rating": 7,
    "date": "2023-08-05",
    "usefulCount": 10,
    "sentiment": "Negative",
    "namedEntities": ["Bentracimab", "Brilinta", "Regulatory Process"]
  },
  {
    "uniqueID": 5,
    "drugName": "Bentracimab",
    "condition": "Antidote for Ticagrelor (Brilinta)",
    "review": "Bentracimab is a game-changer. It neutralized the effects of Brilinta within minutes. No lingering issues. Impressed with the results. Positive experience with a clinical trial in multiple locations.",
    "rating": 9,
    "date": "2023-09-21",
    "usefulCount": 18,
    "sentiment": "Positive",
    "namedEntities": ["Bentracimab", "Brilinta", "Clinical Trial"]
  },
  {
    "uniqueID": 6,
    "drugName": "Bentracimab",
    "condition": "Antidote for Ticagrelor (Brilinta)",
    "review": "No hesitation in recommending Bentracimab. Swift action and no adverse reactions. Satisfied with its performance. Collaborated with a renowned research organization.",
    "rating": 8,
    "date": "2023-10-08",
    "usefulCount": 14,
    "sentiment": "Positive",
    "namedEntities": ["Bentracimab", "Brilinta", "Research Organization"]
  },
  {
    "uniqueID": 7,
    "drugName": "Bentracimab",
    "condition": "Antidote for Ticagrelor (Brilinta)",
    "review": "Bentracimab deserves praise. Rescued me from Brilinta complications. Grateful for its existence. Experienced delays in the regulatory approval process.",
    "rating": 9,
    "date": "2023-11-17",
    "usefulCount": 16,
    "sentiment": "Negative",
    "namedEntities": ["Bentracimab", "Brilinta", "Regulatory Process"]
  },
  {
    "uniqueID": 8,
    "drugName": "Bentracimab",
    "condition": "Antidote for Ticagrelor (Brilinta)",
    "review": "Impressed with the efficacy of Bentracimab. Resolved Brilinta-related issues promptly. No complaints. Engaged in a successful clinical trial phase.",
    "rating": 9,
    "date": "2023-12-04",
    "usefulCount": 22,
    "sentiment": "Positive",
    "namedEntities": ["Bentracimab", "Brilinta", "Clinical Trial"]
  },
  {
    "uniqueID": 9,
    "drugName": "Bentracimab",
    "condition": "Antidote for Ticagrelor (Brilinta)",
    "review": "Bentracimab delivered as promised. Quick relief from Brilinta effects. No issues during the recovery process. Encountered challenges with the regulatory body.",
    "rating": 8,
    "date": "2024-01-12",
    "usefulCount": 19,
    "sentiment": "Negative",
    "namedEntities": ["Bentracimab", "Brilinta", "Regulatory Body"]
            }
    ]
}
)

export default data;